These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14090776)

  • 1. EXCRETION OF DOPAMINE, CATECHOLAMINE METABOLITES AND 5-HYDROXYINDOLEACETIC ACID IN HEPATOLENTICULAR DEGENERATION (WILSON'S DISEASE).
    SOURKES TL; MURPHY GF; SANKOFF I; WISEMAN-DISTLER MH; SAINTCYR S
    J Neurochem; 1963 Dec; 10():947-51. PubMed ID: 14090776
    [No Abstract]   [Full Text] [Related]  

  • 2. [ELIMINATION OF THE PRINCIPAL URINARY METABOLITES OF SEROTONIN, DOPAMINE, NORADRENALINE, AND ADRENALINE DURING TREATMENT WITH RESERPINE AND WITH CHLOROPROMAZINE IN SCHIZOPHRENIC SUBJECTS. CLINICO-BIOLOGICAL CORRELATIONS].
    BRUNO A; BOZZI R; ALLEGRANZA A; DEVITO C
    Riv Patol Nerv Ment; 1963 Sep; 84():451-92. PubMed ID: 14153094
    [No Abstract]   [Full Text] [Related]  

  • 3. ETHANOL AND URINARY CATECHOLAMINES IN MAN.
    ANTON AH
    Clin Pharmacol Ther; 1965; 6():462-9. PubMed ID: 14314969
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of alumina, sephadex G10, and ion-exchange columns to purify samples for determination of epinephrine, norepinephrine, dopamine, homovanillic acid, and 5-hydroxyindoleacetic acid in urine.
    Westerink BH; Bosker FJ; O'Hanlon JF
    Clin Chem; 1982 Aug; 28(8):1745-8. PubMed ID: 6178533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. URINARY EXCRETION OF PHENOLIC ACIDS IN HUMAN SUBJECTS ON A GLUCOSE DIET.
    VONSTUDNITZ W; ENGELMAN K; SJOERDSMA A
    Clin Chim Acta; 1964 Mar; 9():224-7. PubMed ID: 14152336
    [No Abstract]   [Full Text] [Related]  

  • 6. Advanced catecholaminergic disturbances in the brain in a case of Wilson's disease.
    Nyberg P; Gottfries CG; Holmgren G; Persson S; Roos BE; Winblad B
    Acta Neurol Scand; 1982 Jan; 65(1):71-5. PubMed ID: 6175159
    [No Abstract]   [Full Text] [Related]  

  • 7. DEHYDROXYLATION OF SOME CATECHOLAMINES AND THEIR PRODUCTS.
    SMITH AA; FABRYKANT M; KAPLAN M; GAVITT J
    Biochim Biophys Acta; 1964 Jun; 86():429-37. PubMed ID: 14198721
    [No Abstract]   [Full Text] [Related]  

  • 8. [The excretion of vanilmandelic acid, vanillic acid, homovanillic acid and 5-hydroxyindoleacetic acid by urine in smokers and non-smokers].
    Schmid E; Tautz NA; Bauersachs E; Krautheim J
    Arzneimittelforschung; 1968 Jul; 18(7):819-21. PubMed ID: 5755826
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of 1,4-dimethoxyphenylethylamine injections on catecholamine metabolism in rats and monkeys.
    Barbeau A; Singh F; Joubert M
    Life Sci; 1966 Apr; 5(8):757-67. PubMed ID: 4960143
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metabolism of serotonin in Wilson's disease].
    Gandullia E
    Minerva Pediatr; 1966 Dec; 18(37):2165-7. PubMed ID: 5998503
    [No Abstract]   [Full Text] [Related]  

  • 11. TUMORS OF NEURAL CREST ORIGIN; BIOCHEMICAL AND PATHOLOGICAL CORRELATION.
    GREER M; ANTON AH; WILLIAMS CM; ECHEVARRIA RA
    Arch Neurol; 1965 Aug; 13():139-48. PubMed ID: 14318483
    [No Abstract]   [Full Text] [Related]  

  • 12. [URINARY ELIMINATION OF VANYLMANDELIC ACID AND 5-HYDROXY-INDOLACETIC ACID DURING PREGNANCY IN A SUBJECT OPERATED ON FOR PHEOCHROMOCYTOMA].
    BATTAGLIA GB
    Riv Ostet Ginecol; 1964 Jun; 19():346-52. PubMed ID: 14178269
    [No Abstract]   [Full Text] [Related]  

  • 13. EFFECT OF DRUGS ON THE LEVELS OF INDOLE AND PHENOLIC ACIDS IN THE CENTRAL NERVOUS SYSTEM.
    ROOS BE; ANDEN NE; WERDINIUS B
    Int J Neuropharmacol; 1964 Apr; 3():117-22. PubMed ID: 14334586
    [No Abstract]   [Full Text] [Related]  

  • 14. FAMILIAL DYSAUTONOMIA; STUDIES IN A NEWBORN INFANT.
    GELTZER AI; GLUCK L; TALNER NS; POLESKY HF
    N Engl J Med; 1964 Aug; 271():436-40. PubMed ID: 14171813
    [No Abstract]   [Full Text] [Related]  

  • 15. BASAL COPPER EXCRETION IN WILSON'S DISEASE.
    WARREN CB; BROUGHTON PM
    Arch Dis Child; 1964 Jun; 39(205):265-7. PubMed ID: 14169457
    [No Abstract]   [Full Text] [Related]  

  • 16. ENDOGENOUS METABOLIC FACTOR IN SCHIZOPHRENIC BEHAVIOR.
    BERLET HH; BULL C; HIMWICH HE; KOHL H; MATSUMOTO K; PSCHEIDT GR; SPAIDE J; TOURLENTES TT; VALVERDE JM
    Science; 1964 Apr; 144(3616):311-3. PubMed ID: 14169724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COPPER metabolism and amino acid excretion in Wilson's disease.
    Nutr Rev; 1954 Oct; 12(10):304-5. PubMed ID: 13203840
    [No Abstract]   [Full Text] [Related]  

  • 18. [Wilson's disease or hepatolenticular degeneration].
    Mensing B; Nowak A; Zweifel S; Terracciano L; Bernsmeier C; Filipowicz Sinnreich M
    Ther Umsch; 2018 Nov; 75(4):241-248. PubMed ID: 30468117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RF VALUES OF SOME CATECHOLAMINES, PRECURSORS AND METABOLITES.
    MCGEER EG; CLARK WH
    J Chromatogr; 1964 Mar; 13():107-11. PubMed ID: 14155324
    [No Abstract]   [Full Text] [Related]  

  • 20. Variations of urinary creatinine and its correlation to excretion of indole metabolites in mental patients.
    Pscheidt GR; Berlet HH; Spaide J; Himwich HE
    Clin Chim Acta; 1966 Feb; 13(2):228-34. PubMed ID: 5941740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.